- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medicaid Enrollees Receive Fewer Preventive Services From Physicians
A study published in Health Affairs has found that primary care physicians refer women Medicaid enrollees to fewer preventive services than do their counterparts with private insurance coverage.
A study published in Health Affairs has found that primary care physicians refer women Medicaid enrollees to fewer preventive services than do their counterparts with private insurance coverage.
Using data from the National Ambulatory Medical Care Survey, researchers at the Urban Institute examined how office-based primary care practices provided 5 recommended preventive services over a 5-year period. These services included clinical breast exams, pelvic exams, mammograms, Pap tests, and depression screening. The data were collected for visits between 2006 and 2010. The results: 26% of visits by women with Medicaid included at least 1 of the 5 services, compared with 31% of the visits by privately insured women.
According to the lead study author Stacey McMorrow, Medicaid patients were much less likely to receive a breast exam or a Pap test compared with their privately-insured counterparts.
Read more at Kaiser Health News: http://bit.ly/1LKfrpq
Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage
March 11th 2025The authors argue that the stimulant shortage is being perpetuated by the overdiagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults because executive functioning deficits are not included in diagnostic criteria.
Read More
Reviving the Classics: The Role of Older Medications in Modern Dermatology
March 9th 2025Older, generic medications, including ones for cyclosporine, nicotinamide, and dapsone, can effectively treat patients with various dermatological conditions while helping to reduce insurance and cost barriers.
Read More
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
